Kojin Therapeutics

Kojin Therapeutics

Biotechnology, 1 Kendall Sq BLDG 200 Ste 001, Cambridge, Massachusetts, 02139, United States, 11-50 Employees

kojintx.com

  • twitter
  • LinkedIn

phone no Phone Number: 17*********

Who is KOJIN THERAPEUTICS

Based in Boston, Massachusetts and named after the Japanese deity that tamed fire for the good of humanity, Kojin is harnessing groundbreaking discoveries in cell-state and ferroptosis bi...

Read More

map
  • 1 Kendall Sq BLDG 200 Ste 001, Cambridge, Massachusetts, 02139, United States Headquarters: 1 Kendall Sq BLDG 200 Ste 001, Cambridge, Massachusetts, 02139, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from KOJIN THERAPEUTICS

Kojin Therapeutics Org Chart and Mapping

Employees

Gaochao Tian

Senior Director, Head of Enzymology

Eric Shen

Director, Corporate Development & Operations

Vasanthi Viswanathan

Co-Founder, Head of Biology

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Kojin Therapeutics

Answer: Kojin Therapeutics's headquarters are located at 1 Kendall Sq BLDG 200 Ste 001, Cambridge, Massachusetts, 02139, United States

Answer: Kojin Therapeutics's phone number is 17*********

Answer: Kojin Therapeutics's official website is https://kojintx.com

Answer: Kojin Therapeutics's revenue is $1 Million to $5 Million

Answer: Kojin Therapeutics has 11-50 employees

Answer: Kojin Therapeutics is in Biotechnology

Answer: Kojin Therapeutics contact info: Phone number: 17********* Website: https://kojintx.com

Answer: Based in Boston, Massachusetts and named after the Japanese deity that tamed fire for the good of humanity, Kojin is harnessing groundbreaking discoveries in cell-state and ferroptosis biology to develop first-in-class treatments for use in patients with cancer, and cardiovascular, immunologic, and degenerative diseases. Kojin has developed a drug-discovery platform that integrates computational chemistry, structural biology, chemical biology, target-informed screening, and mechanism-driven pharmacology to discover therapeutics that specifically modulate ferroptosis. The Kojin founding team brings together leadership in chemical biology, genetics, immunology, cancer therapeutics, and drug discovery and development, and includes: Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan and Vasanthi Viswanathan.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access